PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: GTCbio - Biopharmaceutical Conference

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Susan Richards VP at Genzyme to Give Keynote Speech at Immunodiagnostics & Immunomonitoring Conference - Dr. Susan Richards, Group VP of Clinical Laboratory Sciences at Genzyme is scheduled to give the keynote presentation at GTCbio’s 3rd annual Immunodiagnostics & Immunomonitoring Conference
Susan Richards VP at Genzyme to Give Keynote Speech at Immunodiagnostics & Immunomonitoring Conference

 

NewswireToday - /newswire/ - Monrovia, CA, United States, 2009/01/23 - Dr. Susan Richards, Group VP of Clinical Laboratory Sciences at Genzyme is scheduled to give the keynote presentation at GTCbio’s 3rd annual Immunodiagnostics & Immunomonitoring Conference.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Sue Richards, Ph.D., Group Vice President of Clinical Laboratory Sciences at Genzyme Corporation in Framingham, MA will give the keynote address entitled “Immunogenicity of Protein Therapeutics: Strategies and Implications.” at GTCbio’s 3rd annual Immunodiagnostics & Immunomonitoring Conference on April 23-24, 2009 in Chicago, IL.

Dr. Richards will provide the attendees with an overview of immunogenicity of recombinant human therapeutic proteins. She will explain risk-based assessment and provide a strategy for immunomonitoring. She will also provide analytical approaches to assess immunogenicity and clinical consequences of anti-drug antibodies.

Dr. Richards has been at Genzyme for twenty years and is responsible for directing and supervising the Immunology and Clinical Laboratory Science Departments. Dr. Richards worked for E.I. Dupont de Nemours & Co. for five years in the Medical Products Division prior to joining Genzyme. Dr. Richards received her Ph.D. in Microbiology from SUNY at Buffalo, and completed a postdoctoral fellowship at the Wadsworth Center for Laboratories and Research in Albany, NY in the Vaccinia Virus Vaccine Program.

Dr. Richards’ presentation, along with over 25 other distinguished speakers, can be heard by attending the 3rd Annual Immunodiagnostics & Immunomonitoring Conference on April 23-24, 2009 in Chicago, IL. The conference will cover novel approaches & methods for immunodiagnostics, evaluation of innovative immunodiagnostic techniques, immunomonitoring of clinical trials, innovative techniques for future clinical use, and biomarkers in immunodiagnostics & immunomonitoring.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: GTCbio - Biopharmaceutical Conference

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Susan Richards VP at Genzyme to Give Keynote Speech at Immunodiagnostics & Immunomonitoring Conference

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Rania Hafez 
626-256-6405 infogtcbio[.]gtcbio.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any GTCbio - Biopharmaceutical Conference securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From GTCbio - Biopharmaceutical Conference / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

First Pulmonary Embolism Patients in Hong Kong Treated with the EKOS® System
Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Genentech’s Cancer Immunotherapy Tecentriq® (Atezolizumab) Priority Review in Additional Type of Advanced Bladder Cancer
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) for Myopic Choroidal Neovascularization
Sugar Element of Keratan Sulfate Halts the Progress of Emphysema Finds RIKEN
Exelixis and Ipsen Amend Exclusive Licensing Agreement for the Commercialization and Development of Cabozantinib to Include Canada
FDA Extends Review of Application for OCREVUS™ (Ocrelizumab)
MDxHealth Announces AceCGT Life Science Limited as the Exclusive Distributor for SelectMDx in Hong Kong and Macao China
Pulse Certified As A Level Four Multichannel Content Agency by Veeva Systems
BD Launches Advanced Prefillable Syringe for Higher Volume Injection of Biologics
Sartorius Announces Expansion of Sartorius Stedim Cellca
Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
BD Integrating Technology, Expertise and Services to Provide Comprehensive Medication Management
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  NAKIVO, Inc.





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)